Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Merck's consumer...

    Merck's consumer health sale at risk as Nestle bows out, says report

    Written by Ruby Khatun Khatun Published On 2018-02-06T09:45:04+05:30  |  Updated On 16 Aug 2021 5:06 PM IST

    The sale of Merck KGaA's consumer health unit has been thrown off track after Nestle has pulled out, leaving the race to buy the maker of Seven Seas vitamins without its main contender, sources familiar with the matter told Reuters.


    Nestle has walked away from the process, led by JPMorgan, after months of negotiations as the Swiss company was put off by Merck's price expectations of about $4.99 billion, sources said. Nestle and Merck declined to comment. A spokesman for Merck said that "the process of evaluating options for our consumer health business is well on track."


    Four sources familiar with the sale said that interest from other bidders, including British consumer goods giant Reckitt Benckiser, was also waning as a rival consumer health auction, led by Pfizer, was gaining momentum. Nestle was initially seen as a natural buyer for the business, which also makes Bion nutritional supplements after previous talks to set up a consumer joint venture with Merck fell through over the summer. Consumer health is a fragmented sector ranging from over-the-counter medicines and vitamins to sports nutrition products and condoms.


    It has proved fertile ground for deals in recent years, as ageing population and health-conscious consumers drive demand. Nestle's CEO Mark Schneider is a healthcare veteran and wants a deeper focus on nutrition, health and wellness.But the Swiss food group could not reach an agreement on price as Merck was targeting a valuation as high as 20 times the unit's core earnings, said a source. Another source said mounting pressure from Third Point, which last year made a $3.5 billion investment in Nestle, also played a role in deciding against buying the Merck's business.

    consumer healthconsumer health businessHealthcareJPMorganMark SchneiderMerckNestlePfizerReckitt BenckiserSaleSeven Seas vitamins
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok